Pre-clinical modeling of cutaneous melanoma
Despite the new targeted and immunotherapies for metastatic melanoma, several patients show therapeutic plateau. Here, the authors review the current pre-clinical models of cutaneous melanoma and discuss their strengths and limitations that may help with overcoming therapeutic plateau.
Enregistré dans:
Auteurs principaux: | Vito W. Rebecca, Rajasekharan Somasundaram, Meenhard Herlyn |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0003348e52b44f61bda3eaf9e47fe9f7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
par: Jinah Kim, et autres
Publié: (2011) -
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
par: Johannes Griss, et autres
Publié: (2019) -
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
par: Rebecca Adams, et autres
Publié: (2021) -
Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
par: Alessandra Buja, et autres
Publié: (2021) -
HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics.
par: Ke-Jun Chen, et autres
Publié: (2021)